Trial Profile
Comparison of the Treatment of Refractory Bladder Pain Syndrome With Dimethyl Sulfoxide (DMSO) Alone and DMSO as a Carrier Molecule for Botulinum Toxin A Instillation.
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 13 Jun 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Dimethyl sulfoxide
- Indications Bladder disorders; Interstitial cystitis
- Focus Therapeutic Use
- 08 Jun 2017 Status changed from active, no longer recruiting to completed.
- 07 Apr 2017 New trial record